GLP1R and heart failure: The observational nature of our data precluded inference of causality, which might be confirmed in future research, such as in ongoing RCTs evaluating the efficacy of tirzepatide in improving cardiovascular and kidney outcomes compared with GLP-1 agonists52 and in treating patients with heart failure with preserved ejection fraction.53